. Additional data from high-resolution immunofluorescent microscopy imaging of brain biopsy analysis. (A) Biopsies from meningitis patients showing that pIgR and PEC AM-1 are expressed on the BBB endothelium and colocalize with pneumococci. Immunofluorescent stainings, using the high-resolution Delta Vision Elite Imaging System, of six human biopsies from patients who died of pneumococcal meningitis caused by different serotypes. Each row shows images related to the section of one blood vessel selected as a representative among 50 blood vessels/patient imaged. (Left) Immunofluorescent detection of S. pneumoniae (red) and bacteria that colocalize with pIgR and PEC AM-1 (white). (Middle) Immunofluorescent staining of pIgR (green), PEC AM-1 (blue), and colocalization of pIgR and PEC AM-1 (white). (Right) Immunofluorescent staining of PEC AM-1 (blue), pIgR (green), and S. pneumoniae (red). The overlay shows that most pneumococci colocalize with both PEC AM-1 and pIgR simultaneously (white; as shown in the middle panel) or with PEC AM-1 or pIgR only. (Graph) Calculation of the percentage of pneumococci that colocalize with pIgR, PEC AM-1, or both receptors among all pneumococci that adhered to the BBB (set to 100%). For each serotype, the total percentages of colocalized and noncolocalized bacteria were calculated using the total amounts of colocalized and noncolocalized bacteria in 50 blood vessels/patient imaged. (B) Pneumococci do not colocalize with EPCR on the BBB endothelium in human brain biopsies. High-resolution immunofluorescent microscopy was performed on brain tissue sections from six meningitis patients. Each image (one for each patient) shows the section of a blood vessel selected as representative among 50 blood vessels per patient studied. Immunofluorescent detection of BBB endothelium (red), EPCR (green), and S. pneumoniae (blue) show that pneumococci do not colocalize with EPCR. (C) The passage of pneumococci across the BBB occurs without major disruptions of the vascular endothelium. 3D model images (z-stacks) taken with the Delta Vision Elite Imaging System. The yz axes show the angle of rotation of each image. Each image shows one representative image per each patient, including the three images of the uninfected brains (each image is representative of each uninfected patient). The panel "VE-Cadherin S. pneumoniae" shows bacteria (green) that adhered to the vascular endothelium (red), the panel "VE-Cadherin" shows the same images only with the VE-cadherin fluorescent signal showing the continuous endothelial layer also in the vessels in which bacteria were detected, indicating no major disruptions of the endothelium caused by the bacterial infection. Each image (one for each patient) shows the section of a blood vessel selected as a representative among the 10 blood vessels/patient analyzed. Figure S2 . IVIS imaging analysis detecting bioluminescent pneumococci in the brain in vivo. (A) IVIS imaging analysis detecting bioluminescent pneumococci and quantification of the signal intensity in the brain of mice in the absence or blockade of one receptor (before and after infection). (B) IVIS imaging analysis detecting bioluminescent pneumococci and quantification of the signal intensity in the brain of mice in the absence or blockade of both receptors (before and after infection). (C) Numbers of pneumococci found in the brain 14 h after intravenous infection with bioluminescent TIGR4 of pIgR −/− mice treated with anti-pIgR antibody. The number of pneumococci detected was similar to those found in the brain of pIgR −/− mice; IVIS imaging analysis detecting bioluminescent pneumococci and quantification of the signal intensity in the brain of mice. (D) Numbers of pneumococci found in the brain 14 h after intravenous infection with bioluminescent TIGR4 of PEC AM-1 −/− mice treated with anti-PEC AM-1 antibody. The number of pneumococci detected were similar to those found in the brain of PEC AM-1 −/− mice; IVIS imaging analysis detecting bioluminescent pneumococci and quantification of the signal intensity in the brain of mice. (E) Numbers of pneumococci found in the brain 14 h after intravenous infection with bioluminescent TIGR4 of WT mice treated with anti-EPCR antibody (before or after the infection). The number of pneumococci detected were similar to those found in the brain of nontreated WT mice; IVIS imaging analysis detecting bioluminescent pneumococci and quantification of the signal intensity in the brain of mice. (F) Number of pneumococci found in the brain 14 h after intravenous infection with bioluminescent TIGR4 coupled with anti-RrgA and anti-PspC antibodies or anti-PspA antibody compared with infection with uncoupled bioluminescent TIGR4; IVIS imaging analysis detecting bioluminescent pneumococci and quantification of the signal intensity in the brain of mice. **, P < 0.01. (G) Numbers of pneumococci found in the brain 14 h after intravenous infection with bioluminescent TIGR4 of WT mice infected with bioluminescent TIGR4 intravenously and then treated with ceftriaxone only or with ceftriaxone and antibodies to the receptors, pIgR and PEC AM-1, 1 h after infection; IVIS imaging analysis detecting bioluminescent pneumococci and quantification of the signal intensity in the brain of mice. Error bars show standard deviations. In each graph, each column shows the mean value of the intensity of the bioluminescent signals in the brain of the mice, and each column has three means and three standard deviations (three error bars, as there are three colors that have been quantified: red, green, and blue). Each standard deviation was calculated using the intensity values of each color in the brain of each mouse used in the experiment. The horizontal bars in C-F show the mean values. Labeling kits were used when two secondary antibodies would have cross-reacted in the same staining. 
